Transcriptomic effects of chronic inflammatory pain in alcohol-responsive midbrain cells - project summary______________________________________________________________________ chronic pain is a major…

Active Grant Awarded

Award ID
R21AA032574
Recipient
Awarding agency
Obligated
$393,750

Award facts

Assistance listing
93.273 Alcohol Research Programs
Completion date 10% complete
Place of performance
New Orleans, LA 70112, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services' National Institutes of Health, through the National Institute on Alcohol Abuse and Alcoholism, awarded Louisiana State University Health Sciences Center New Orleans a grant obligating $393,750 on September 9, 2026, under Assistance Listing 93.273, Alcohol Research Programs. The award funds research titled "Transcriptomic Effects of Chronic Inflammatory Pain in Alcohol-Responsive Midbrain Cells." The project will identify alcohol-responsive cells in a descending pain modulation circuit and use single-cell resolution to profile their transcriptional response to chronic pain. The investigators hypothesize that a subset of midbrain cells projecting to the rostral ventral medulla (RVM) is uniquely recruited to encode pain and the anti-nociceptive effects of alcohol. Specific Aim 1 identifies RVM projector subsets that respond to an analgesic dose of alcohol. The project period runs from the September 9, 2026 award date to an ultimate completion date of August 31, 2028, with work performed in New Orleans, Louisiana 70112. The program's stated purpose is to build a fundamental knowledge base for improved methods of treating alcoholism and alcohol-related problems and for preventing them.

Description

Transcriptomic effects of chronic inflammatory pain in alcohol-responsive midbrain cells - project summary______________________________________________________________________ chronic pain is a major health problem in the united states, and over-prescription of opioid drugs has led to an epidemic in the united states that includes high rates of opioid addiction and mortality. Promising strategies for reducing reliance on opioids include those that improve our understanding of CNS circuits mediating chronic pain, and those that identify other molecules that effectively reduce pain. There is a complex bidirectional relationship between alcohol and pain. Individuals living with chronic pain have higher prevalence of alcohol misuse, in part because alcohol is a powerful analgesic. In a RAT model of inflammatory pain (complete freund's adjuvant [CFA]), acute alcohol dose-dependently attenuates mechanical and thermal hypersensitivity in CFA- treated rats. The pain alleviating properties of alcohol in humans has been documented for centuries, yet the molecular and cellular mechanisms underlying alcohol analgesia are not known. Here we propose to fill this GAP in knowledge by identifying alcohol-responsive cells in a descending pain modulation circuit and using single cell resolution to profile the transcriptional response to chronic pain in those cells. Our preliminary data indicate that chronic pain activates a subpopulation of midbrain cells, and that acute treatment with an analgesic dose of alcohol attenuates this effect, suggesting that chronic pain and an analgesic dose of alcohol oppositely regulate the activity of these cells. More specifically, we hypothesize that a subset of midbrain cells that project to the rostral ventral medulla (RVM) is uniquely recruited to encode pain and the anti-nociceptive effects of alcohol. In specific aim 1, we will identify subsets of RVM projectors that are responsive to an analgesic dose of alcohol, and we will comprehensively profile the transcriptomes of those cells to determine their molecular identify and identify chronic pain-induced neuroadaptations in those cells. In specific aim 2, we will validate differential gene expression of top candidate genes in specific cell populations using RNA in situ hybridization. This proposal leverages the complementary expertise of two highly collaborative labs. The goal of this work is to identify key molecular changes induced by chronic pain in alcohol-responsive midbrain cells in order to facilitate testing of novel therapeutics for pain management.

Quick answers

Who received award R21AA032574?

R21AA032574 was awarded to Louisiana State University Health Sciences Center New Orleans by National Institute on Alcohol Abuse and Alcoholism (National Institutes of Health) on September 9, 2026.

How much is award R21AA032574 worth?

$393,750 has been obligated on R21AA032574.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award